Skip to main content

Alimera Sciences Inc

ALIMDelisted Sep 16, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001267602

Alimera Sciences Inc was delisted on Sep 16, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 52 institutions reported holding it in 13F filings for Q2 2024, worth $257.9M in total; no superinvestor held it.

Q4 2023 vs. Q3 2023

How the institutions holding Alimera Sciences Inc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of ALIM: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders3035+5
Shares47.3M48.2M+977.5K (+2.1%)
Value$146.5M$208.4M+$61.9M (+42.2%)

New holders (8)

Institutions that held Alimera Sciences Inc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to ALIM in Q4 2023
InstitutionSharesValue% of portfolio
Bank of Montreal124,297$541.9K0.00%
Susquehanna International Group, LLP110,610$477.8K0.00%
Balyasny Asset Management LLC40,032$172.9K0.00%
HighTower Advisors, LLC25,091$108.0K0.00%
Citadel Advisors LLC19,874$85.9K0.00%
ExodusPoint Capital Management, LP19,376$84.0K0.00%
Northern Trust Corp14,132$61.0K0.00%
UBS Group AG2$90.00%

Sold out (3)

Institutions that held Alimera Sciences Inc at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of ALIM in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Healthcare of Ontario Pension Plan Trust Fund250,000$775.0K
Perritt Capital Management Inc10,000$31.0K
Barclays PLC36$112